Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Elanco Animal Health Incorporated before investing.

In this article, we go over a few key elements for understanding Elanco Animal Health Incorporated’s stock price such as:

• Elanco Animal Health Incorporated’s current stock price and volume
• Why Elanco Animal Health Incorporated’s stock price changed recently
• Upgrades and downgrades for ELAN from analysts
• ELAN’s stock price momentum as measured by its relative strength

About Elanco Animal Health Incorporated (ELAN)

Before we jump into Elanco Animal Health Incorporated’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. It also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, the company offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, it offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and Tru Family trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. The company sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Indianapolis, Indiana.

Want to learn more about Elanco Animal Health Incorporated’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Elanco Animal Health Incorporated.

Elanco Animal Health Incorporated’s Stock Price as of Market Close

As of April 28, 2026, 10:17 AM, CST, Elanco Animal Health Incorporated’s stock price was $22.595.

Elanco Animal Health Incorporated is up 2.29% from its previous closing price of $22.090.

During the last market session, Elanco Animal Health Incorporated’s stock traded between $22.100 and $22.750. Currently, there are approximately 496.90 million shares outstanding for Elanco Animal Health Incorporated.

Elanco Animal Health Incorporated’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Elanco Animal Health Incorporated Stock Price History

Elanco Animal Health Incorporated’s (ELAN) price is currently down 5.58% so far this month.

During the month of April, Elanco Animal Health Incorporated’s stock price has reached a high of $24.480 and a low of $21.760.

Over the last year, Elanco Animal Health Incorporated has hit prices as high as $27.720 and as low as $9.320. Year to date, Elanco Animal Health Incorporated’s stock is down 0.15%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Elanco Animal Health Incorporated Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 27, 2026, there was 1 analyst who downgraded Elanco Animal Health Incorporated’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Elanco Animal Health Incorporated’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Elanco Animal Health Incorporated’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Elanco Animal Health Incorporated’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Elanco Animal Health Incorporated (ELAN) by visiting AAII Stock Evaluator.

Relative Price Strength of Elanco Animal Health Incorporated

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 27, 2026, Elanco Animal Health Incorporated has a weighted four-quarter relative price strength of 11.74%, which translates to a Momentum Score of 83 and is considered to be Very Strong.

Want to learn more about how Elanco Animal Health Incorporated is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Elanco Animal Health Incorporated Stock Price: Bottom Line

As of April 28, 2026, Elanco Animal Health Incorporated’s stock price is $22.595, which is up 2.29% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Elanco Animal Health Incorporated stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.